환자 맞춤형 수술기구 개발부터 디지털 헬스케어를 위한 다양한 제품 및 프로그램 개발이 진행되고 있습니다.
High Tibial Osteotomy (HTO) is a surgical procedure that corrects the alignment of a bent leg axis caused by medial compartment arthritis of the knee. It is performed when the condition is not severe enough to warrant joint replacement. HTO PLATE is a medical device used in performing high tibial osteotomy.
Unicompartmental Knee Replacement (UKR) is a surgical procedure that involves replacing only one side (either the medial or lateral compartment) of the knee joint with an artificial joint. It is performed when only one side of the joint, either the medial or lateral compartment, has cartilage damage. UKR is commonly performed in younger patients where the functional aspect of the joint is important.
Despite the fact that the shape of the knee varies among patients, traditional artificial joints are standardized in 8 to 10 sizes. To overcome this limitation, a product under development is custom-made artificial joints. Custom-made artificial joints are designed and manufactured taking into consideration the shape and dimensions of each patient's knee.
Despite the fact that the shape of the knee varies among patients, traditional artificial joints are standardized in 8 to 10 sizes. To overcome this limitation, a product under development is custom-made artificial joints. Custom-made artificial joints are designed and manufactured taking into consideration the shape and dimensions of each patient's knee.
Ultrasound therapy is a method of relieving pain using ultrasound waves. Joint ultrasound therapy can be helpful in the treatment of osteoarthritis.
Sustained-release injectables are therapeutic agents administered through injection once every 1-3 months to reduce the frequency of medication administration or minimize side effects.
The objective is to use microspheres made of biodegradable polymer materials to release the drug slowly over an extended period within the body, thereby prolonging the duration of drug efficacy and increasing patient convenience.The goal is to develop a method for manufacturing microspheres and drug delivery technology and apply them to the development of injectable therapies for arthritis.
이메일주소 무단수집을 거부합니다.
본 웹사이트에 게시된 이메일 주소가 전자우편 수집 프로그램이나 그 밖의 기술적 장치를 이용하여 무단으로 수집되는 것을 거부하며, 이를 위반시 정보통신망법에 의해 형사 처벌됨을 유념하시기 바랍니다.